These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 9056668)
1. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. Staley CA; Parikh NU; Gallick GE Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668 [TBL] [Abstract][Full Text] [Related]
2. Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases. Han NM; Curley SA; Gallick GE Clin Cancer Res; 1996 Aug; 2(8):1397-404. PubMed ID: 9816313 [TBL] [Abstract][Full Text] [Related]
3. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101 [TBL] [Abstract][Full Text] [Related]
4. c-Yes tyrosine kinase activity in human colon carcinoma. Park J; Meisler AI; Cartwright CA Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925 [TBL] [Abstract][Full Text] [Related]
5. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase. Fleming RY; Ellis LM; Parikh NU; Liu W; Staley CA; Gallick GE Surgery; 1997 Aug; 122(2):501-7. PubMed ID: 9288158 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells. Marchetti D; Parikh N; Sudol M; Gallick GE Oncogene; 1998 Jun; 16(25):3253-60. PubMed ID: 9681823 [TBL] [Abstract][Full Text] [Related]
8. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line. Lansing TJ; Turk BF; Kanner SB; Gilmer TM Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992 [TBL] [Abstract][Full Text] [Related]
9. Decreased CHK protein levels are associated with Src activation in colon cancer cells. Zhu S; Bjorge JD; Cheng HC; Fujita DJ Oncogene; 2008 Mar; 27(14):2027-34. PubMed ID: 17934522 [TBL] [Abstract][Full Text] [Related]
10. Expression of C-terminal src kinase in human colorectal cancer cell lines. Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential. Irby R; Mao W; Coppola D; Jove R; Gamero A; Cuthbertson D; Fujita DJ; Yeatman TJ Cell Growth Differ; 1997 Dec; 8(12):1287-95. PubMed ID: 9419417 [TBL] [Abstract][Full Text] [Related]
12. Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines. Garcia R; Parikh NU; Saya H; Gallick GE Oncogene; 1991 Nov; 6(11):1983-9. PubMed ID: 1719464 [TBL] [Abstract][Full Text] [Related]
13. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation. Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787 [TBL] [Abstract][Full Text] [Related]
14. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma. Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926 [TBL] [Abstract][Full Text] [Related]
15. Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells. Foss FM; Veillette A; Sartor O; Rosen N; Bolen JB Oncogene Res; 1989; 5(1):13-23. PubMed ID: 2476706 [TBL] [Abstract][Full Text] [Related]
16. Butyrate regulates the expression of c-Src and focal adhesion kinase and inhibits cell invasion of human colon cancer cells. Lee JC; Maa MC; Yu HS; Wang JH; Yen CK; Wang ST; Chen YJ; Liu Y; Jin YT; Leu TH Mol Carcinog; 2005 Aug; 43(4):207-14. PubMed ID: 16001424 [TBL] [Abstract][Full Text] [Related]
17. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Trevino JG; Summy JM; Lesslie DP; Parikh NU; Hong DS; Lee FY; Donato NJ; Abbruzzese JL; Baker CH; Gallick GE Am J Pathol; 2006 Mar; 168(3):962-72. PubMed ID: 16507911 [TBL] [Abstract][Full Text] [Related]
19. Expression of N-myristoyltransferase inhibitor protein and its relationship to c-Src levels in human colon cancer cell lines. Rajala RV; Dehm S; Bi X; Bonham K; Sharma RK Biochem Biophys Res Commun; 2000 Jul; 273(3):1116-20. PubMed ID: 10891381 [TBL] [Abstract][Full Text] [Related]
20. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Brunton VG; Ozanne BW; Paraskeva C; Frame MC Oncogene; 1997 Jan; 14(3):283-93. PubMed ID: 9018114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]